Cardiac Safety in Clinical Trials with Preventive HIV Vaccine Candidates Based on Modified Vaccinia Ankara (MVA)

Cardiac Safety in Clinical Trials with Preventive HIV Vaccine Candidates Based on Modified Vaccinia Ankara (MVA)

Chi tiết về thư mục
Những tác giả chính:	Schmidt, C, Kochhar, S, Excler, J, Smith, C, McMichael, A, Hanke, T, Bwayo, J, Jaoko, W, Weber, J, Kaleebu, P, Peters, B, Pantaleo, G, Vardas, E, Vasan, S, Keefer, M, Ramanathan, V, Boyle, R, Fast, P
Định dạng:	Conference item
Được phát hành:	2008

Những quyển sách tương tự

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.
Bằng: Peters, B, et al.
Được phát hành: (2007)

Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya.
Bằng: Hanke, T, et al.
Được phát hành: (2002)

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.
Bằng: Jaoko, W, et al.
Được phát hành: (2008)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
Bằng: Cottingham, M, et al.
Được phát hành: (2008)

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects.
Bằng: Howles, S, et al.
Được phát hành: (2010)

Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
Bằng: Dorrell, L, et al.
Được phát hành: (2007)

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
Bằng: Mwau, M, et al.
Được phát hành: (2004)

Clinical development of Modified Vaccinia virus Ankara vaccines.
Bằng: Gilbert, S
Được phát hành: (2013)

Clinical development of Modified Vaccinia virus Ankara vaccines
Bằng: Gilbert, S
Được phát hành: (2013)

Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help.
Bằng: Estcourt, M, et al.
Được phát hành: (2005)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
Bằng: Rosario, M, et al.
Được phát hành: (2010)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
Bằng: Dorrell, L, et al.
Được phát hành: (2000)

Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
Bằng: Busquets, N, et al.
Được phát hành: (2011)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
Bằng: Hanke, T, et al.
Được phát hành: (2007)

Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
Bằng: Sharpe, S, et al.
Được phát hành: (2003)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
Bằng: Moorthy, V, et al.
Được phát hành: (2003)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
Bằng: Hanke, T, et al.
Được phát hành: (1998)

Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.
Bằng: Slyker, J, et al.
Được phát hành: (2005)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
Bằng: Gilbert, S, et al.
Được phát hành: (1999)

Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay.
Bằng: Winstone, N, et al.
Được phát hành: (2009)

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.
Bằng: Smith, C, et al.
Được phát hành: (2005)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
Bằng: López-Camacho, C, et al.
Được phát hành: (2019)

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.
Bằng: Wee, E, et al.
Được phát hành: (2002)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Bằng: McConkey, S, et al.
Được phát hành: (2003)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
Bằng: Schneider, J, et al.
Được phát hành: (1998)

Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice.
Bằng: Hanke, T, et al.
Được phát hành: (2005)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
Bằng: Alharbi, N
Được phát hành: (2014)

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
Bằng: Hanke, T, et al.
Được phát hành: (1999)

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity
Bằng: Alharbi, N, et al.
Được phát hành: (2015)

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
Bằng: Allen, T, et al.
Được phát hành: (2000)

Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.
Bằng: Ondondo, B, et al.
Được phát hành: (2006)

Erratum: Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction (Journal of General Virology (2007) vol. 88 ( 1) (1-12))
Bằng: Hanke, T, et al.
Được phát hành: (2008)

Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques.
Bằng: Im, E, et al.
Được phát hành: (2006)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
Bằng: Behboudi, S, et al.
Được phát hành: (2004)

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.
Bằng: Bejon, P, et al.
Được phát hành: (2006)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
Bằng: Moorthy, V, et al.
Được phát hành: (2003)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
Bằng: Moorthy, V, et al.
Được phát hành: (2003)

Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
Bằng: Winslow, R, et al.
Được phát hành: (2017)

Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia Ankara-vectored Ebola vaccines: a randomized clinical trial
Bằng: Milligan, I, et al.
Được phát hành: (2016)

Immunogenicity and reactogenicity of novel adenovirus type 26 and modified vaccinia Ankara-vectored Ebola vaccines: A randomized clinical trial
Bằng: Milligan, I, et al.
Được phát hành: (2016)